Bankinter, Bongrain, Nyrstar, Vopak: European Equity Preview

The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index fell 1.2 percent to 277.88. The Stoxx 50 Index declined 1 percent to 2,611.80. The Euro Stoxx 50 Index, a benchmark for nations using the euro, dropped 0.9 percent to 2,909.73.

Bankinter SA (BKT) : The Spanish lender needs 333 million euros of new capital, the Bank of Spain said. The bank has said it will issue 406 million euros in bonds that must be converted into shares. The stock lost 1.6 percent to 4.58 euros.

Bongrain SA (BH) : The dairy-product manufacturer said net income rose 83 percent in 2010 to 81.4 million euros last year. The company will pay a dividend of 1.6 euros per share. The shares of Bongrain rose 1.2 percent to 62.83 euros.

Nyrstar NV (NYR BB): Existing investors in the world’s largest producer of refined zinc have until 4 p.m. in Brussels to buy seven new shares at 7 euros apiece for every 10 they hold. Nyrstar (NYR) lost 2.5 percent to 9.91 euros. The subscription rights (NYR3 BB) fell 8.6 percent to 2.01 euros.

Royal Vopak NV (VPK NA): The world’s largest chemical and oil storage company may report full-year net income rose to 276.8 million euros, according to the average estimate of nine analysts surveyed by Bloomberg. Vopak retreated 0.9 percent to 34.78 euros.

Telegraaf Media Groep NV (TELEG) : The Dutch newspaper publisher may report full-year profit excluding some items of 52.9 million euros ($73.1 million), according to the average of four analyst estimates compiled by Bloomberg. Telegraaf rose 0.1 percent to 14.32 euros.

ThromboGenics NV (THR) : The Belgian developer of the microplasmin retinal-disorder medicine said it plans to seek U.S. and European regulatory approval for the experimental drug in the second half of 2011. The company had 109.2 million euros of cash and short-term investments on Dec. 31. The shares dropped 0.8 percent to 20.69 euros.

To contact the reporter on this story: Cecile Vannucci in New York at

To contact the editor responsible for this story: Nick Baker at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.